ESSA Pharma Inc. — Investor Relations & Filings
ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on the development of small molecule drugs for the treatment of prostate cancer. The company's core strategy is to develop novel therapies that target the N-terminal domain (NTD) of the androgen receptor (AR). This approach represents a distinct mechanism of action compared to existing treatments that target the ligand-binding domain of the AR. Its lead clinical candidate, EPI-7386, is an investigational oral drug designed to inhibit AR activity and is being developed for patients with castration-resistant prostate cancer (CRPC), including those whose disease has become resistant to current standard-of-care therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2025 | 2025-11-17 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| 15-12G | 2025-10-28 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English | |
| OWNERSHIP DOCUMENT | 2025-10-15 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12852931 | Regulatory Filings 2025 | 2025-11-17 | English | ||
| 12852932 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852935 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12852934 | 15-12G | 2025-10-28 | English | ||
| 12852933 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852936 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852937 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852938 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852939 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852940 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852941 | OWNERSHIP DOCUMENT | 2025-10-15 | English | ||
| 12852942 | POS AM | 2025-10-15 | English | ||
| 12852943 | S-8 POS | 2025-10-15 | English | ||
| 12852944 | S-8 POS | 2025-10-15 | English | ||
| 12852945 | S-8 POS | 2025-10-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Camp4 Therapeutics Corp
Develops RNA-based therapeutics to amplify protein expressi…
|
CAMP | US | Manufacturing |
|
Camurus
Develops and commercializes long-acting medicines for sever…
|
CAMX | SE | Manufacturing |
|
CANbridge Pharmaceuticals Inc.
Global biopharma developing and commercializing transformat…
|
1228 | KY | Manufacturing |
|
Candel Therapeutics, Inc.
Develops viral immunotherapies to activate the immune syste…
|
CADL | US | Manufacturing |
|
Can-Fite BioPharma Ltd.
Clinical-stage biopharma developing oral small-molecule dru…
|
CANF | IL | Manufacturing |
|
Cangene Corporation
Biopharma focused on developing and manufacturing plasma-de…
|
CNJ | CA | Manufacturing |
|
Cannabotech Ltd.
Develops therapies by integrating cannabinoids and medicina…
|
CNTC | IL | Manufacturing |
|
Cannara Biotech Inc.
Large-scale, low-cost producer of premium cannabis products…
|
LOVE | CA | Manufacturing |
|
Cannex Capital Holdings Inc.
Operated across the entire cannabis value chain, producing …
|
CNNX | CA | Manufacturing |
|
CANN GROUP LIMITED
Cultivates, manufactures, and supplies pharmaceutical-grade…
|
CAN | AU | Manufacturing |
ESSA Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35249/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35249 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35249 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35249 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35249}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ESSA Pharma Inc. (id: 35249)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.